Безопасен ли palmitoyl octapeptide-40 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли palmitoyl octapeptide-40 при беременности?

No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety concern located for palmitoyl octapeptide-40; no peer-reviewed evidence of reproductive/teratogenic effects in humans or animals. Typical cosmetic peptides have low dermal bioavailability (CIR, general peptide safety literature). Sources searched: ECHA Annex VI, SCCS/CIR, PubMed, PubChem, CosIng, EWG.

Безопасен ли palmitoyl octapeptide-40 при грудном вскармливании?

No data indicating reproductive or lactation toxicity or breastmilk transfer; no regulatory flags (ECHA Annex VI, SCCS/CIR). Topical peptide of this size is unlikely to reach systemic levels that would pose a breastfeeding hazard based on absence of adverse findings in available databases.

Безопасен ли palmitoyl octapeptide-40 для кожи малыша?

No evidence of developmental or pediatric toxicity. Mechanistic concerns not identified. Exposure scored higher (+1) for infants because infant skin has higher permeability and surface-area-to-weight; although palmitoyl peptides are large and expected to have negligible absorption in adults, infant exposure is considered low but measurable compared with adults. No infant-specific adverse data found.

Как VeriMom оценивает palmitoyl octapeptide-40?

VeriMom оценивает palmitoyl octapeptide-40 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы palmitoyl octapeptide-40 при беременности?

См. наш список безопасных альтернатив palmitoyl octapeptide-40 с аналогичной функцией и классификацией без известных рисков.